wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38042401-68FF84DC-86D9-45E1-BBA4-F19474ABB4BB
Q38042401-68FF84DC-86D9-45E1-BBA4-F19474ABB4BB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38042401-68FF84DC-86D9-45E1-BBA4-F19474ABB4BB
Differences in drug approval processes of 3 regulatory agencies: a case study of gemtuzumab ozogamicin.
P2860
Q38042401-68FF84DC-86D9-45E1-BBA4-F19474ABB4BB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38042401-68FF84DC-86D9-45E1-BBA4-F19474ABB4BB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a0287424776543ddc04c65e759e053e5e1dd3a6
P2860
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group.